|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Percutaneous closure of secundum type atrial septal defects:More than 5-year follow-up显示文摘AIM: To investigate long-term efficacy of two different devices more than five years after percutaneous atrial septal defect(ASD) closure in adults.METHODS: All patients who underwent percutaneous closure of an ASD in the St. Antonius Hospital, Nieuwegein, The Netherlands, between February 1998 and December 2006 were included. Percutaneous closure took place under general anaesthesia and transesophageal echocardiographic moni toring. Transthoracic echocardiography(TTE) was performed 24 h post-procedure to visualize the device position and to look for residual shunting using color Doppler. All complications were registered. All patients were invited for an outpatient visit and contrast TTE more than 5-years after closure. Efficacy was based on the presence of a residual right-to-left shunt(RLS), graded as minimal, moderate or severe. The presence of a residual left-to-right shunt(LRS) was diagnosed using color Doppler, and was not graded. Descriptive statistics were used for patients' characteristics. Univariate analysis was used to identify predictors for residual shunting.RESULTS: In total, 104 patients(mean age 45.5 ± 17.1 years) underwent percutaneous ASD closure using an Amplatzer device(ASO) in 76 patients and a Cardioseal/Starflex device(CS/SF) in 28 patients. The mean follow-up was 6.4 ± 3.4 years. Device migration occurred in 4 patients of whom two cases occurred during the index hospitalization(1 ASO, 1 CS/SF). The other 2 cases of device migration occurred during the first 6 mo of follow-up(2 CS/SF). The recurrent thrombo-embolic event rate was similar in both groups: 0.4% per follow-up year. More than 12 mo post-ASD closure and latest follow-up, new-onset supraventricular tachyarrhythmia's occurred in 3.9% and 0% for the ASO and CS/SF group, respectively. The RLS rate at latest follow-up was 17.4%(minimal 10.9%, moderate 2.2%, severe 4.3%) and 45.5%(minimal 27.3%, moderate 18.2%, severe 0%) for the ASO- and CS/SF groups, respectively. There was no residual LRS in both groups.CONCLUSION: Percutaneous ASD closure has good long-term safety and efficacy profiles. The residual RLS rate seems to be high more than 5 years after closure, especially in the CS/SF. Residual LRS was not observed. | Roel JR Snijder Maarten J Suttorp Jurrien M Ten Berg Martijn C Post | 2015 | World Journal of Cardiology2015，7，3： | 6 |
| 2 | Oocyte-Specific Genes Affect Folliculogenesis,Fertilization,and Early Development显示文摘 | Ping Z Jurrien D | 2007 | Semin Reprod Med2007，25，： | 1 |
| 3 | Relapse of Chronic Hepatitis B After Discontinuation of Nucleos (t) ide Analogs: Is the Glass Half Full or Half Empty? 显示文摘 | Jurrien GP Reijnders MD Harry LA | 2013 | Hepatology2013，58，6： | 1 |
| 4 | Impact of Platelet Reactivity on Clinical Outcomes After Percutaneous Coronary Intervention显示文摘 | Somjot S. Brar Jurrien ten Berg Rossella Marcucci Matthew J. Price Marco Valgimigli Hyo-Soo Kim Giuseppe Patti Nicoline J. Breet Germano DiSciascio Thomas Cuisset George Dangas | 2011 | Journal of the American College of Cardiology2011，，19： | 1 |
| 5 | Maternal control of early mouse development显示文摘 | Lei Li Ping Zheng Jurrien Dean | | 0，，： | 1 |
| 6 | 显示文摘 | Louis C. Almekinders Jurrien H. Vellema Paul S. Weinhold | 2002 | Knee Surgery Sports Traumatology Arthroscopy2002，，1： | 1 |
| 7 | Effect of Prasugrel Pre-Treatment Strategy in Patients Undergoing Percutaneous Coronary Intervention for NSTEMI显示文摘 | Gilles Montalescot Jean-Philippe Collet Patrick Ecollan Leonardo Bolognese Jurrien ten Berg Dariusz Dudek Christian Hamm Petr Widimsky Jean-Fran?ois Tanguay Patrick Goldstein Eileen Brown Debra L. Miller LeRoy LeNarz Eric Vicaut | 2014 | Journal of the American College of Cardiology2014，，： | 1 |
| 8 | Forensic visual evidence显示文摘 | Jurrien Bijhold Arnout Ruifrok Zeno Geradts | 2010 | A Review2010，，： | 1 |
| 9 | Long-term results after successful percutaneous transluminal coronary angioplasty in patients over 75 years of age显示文摘 | Jurrien MB Adriaan AV Maarten JS | 1996 | Am J Cardiol1996，77，： | 1 |
| 10 | Fluorescence Lifetime Heterogeneity in Aggregates of LHC Ⅱ Revealed by Time-resolved Microscopy 显示文摘 | VIRGINIJUS B CEES J G JURRIEN V | 2001 | Biophysical Journal2001，81，1： | 1 |
| 11 | Exploring consumer evaluations of e-services:a portal site显示文摘 | Van Riel A.C.R Liljander V Jurriens P | | 0，，04： | 1 |
| 12 | Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention:A collaborative meta-analysis of individual participant data显示文摘 | Somjot SB Jurrien ten B Rossella M | 2011 | J Am Coil Cardiol2011，58，19： | 1 |
| 13 | ExploringConsumer Evaluations of E-services: a Portal Site显示文摘 | Van Riel ACR Liljander V Jurriens P | 2001 | International Journal of Service Industry Mana-geemnt2001，12，4： | 1 |
| 14 | Exploring Consumer Evaluations of E-services:a Portal site显示文摘 | Van Rid A C R Liljander V Jurriens P | 2001 | International Journal of Service Industry Management2001，12，4： | 1 |
| 15 | Exploring consumer evaluations of e-services: A portal site显示文摘 | Van Riel A C R Liljander V Jurriens P | 2001 | International Journal of Service Industry Management2001，12，4： | 1 |
| 16 | Exploring consumer evaluations of e-services:a portal site显示文摘 | Van Riel A C Liljander V Jurriens P | 2001 | International Journal of Service Industry Management2001，12，4： | 1 |
| 17 | The effect of pre‐hospital glycoprotein IIb–IIIa inhibitors on angiographic outcome in STEMI patients who are candidates for primary PCI显示文摘 | Renicus S.Hermanides J. Woutervan Werkum Jan PaulOttervanger Nicoline J.Breet A.T. MarcelGosselink K. Gertvan Houwelingen Jan‐Henk E.Dambrink ChristianHamm Jurrien M.ten Berg Arnoud W.J.van ’t Hof | 2012 | Cathet Cardiovasc Intervent2012，，6： | 1 |
| 18 | Prehospital initiation of tirofiban in patients with ST- elevation myocardial infarction undergoing primary angioplasty (On- TIME 2) : a muhicentre, double- blind, randomised controlled trial显示文摘 | Arnoud W J van't Hof Jurrien ten Berg Ton Heestermans | 2008 | Lancet2008，372，： | 1 |
| 19 | Hepatitis B Surface Antigen Declines and Clearance During Long-Term Tenofovir Therapy in Patients Coinfected With HBV and HIV显示文摘 | Roeland Zoutendijk Hans L. Zaaijer Theodora E. M. S. de Vries-Sluijs Jurrien G. P. Reijnders Jan W. Mulder Frank P. Kroon Clemens Richter Annemiek A. van der Eijk Milan J. Sonneveld Bettina E. Hansen Robert A. de Man Marchina E. van der Ende Harry L. A. J | 2012 | Journal of Infectious Diseases2012，，6： | 1 |
| 20 | Adding pegylated interferon to entecavir for hepatitis B e antigen–positive chronic hepatitis B: A multicenter randomized trial (ARES study)显示文摘 | Willem Pieter Brouwer Qing Xie Milan J. Sonneveld Ningping Zhang Qin Zhang Fehmi Tabak Adrian Streinu‐Cercel Ji‐Yao Wang Ramazan Idilman Hendrik W. Reesink Mircea Diculescu Krzysztof Simon Mihai Voiculescu Meral Akdogan Wlodzimierz Mazur Jurrien G.P. Reij | 2015 | Hepatology2015，，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员